Better Coronavirus Stock: Moderna or Inovio Pharmaceuticals?
The coronavirus vaccine race offers these clinical stage companies an opportunity to bring a first product to market -- if all goes well in human trials.
Full Article
Better Coronavirus Stock: Moderna or Inovio Pharmaceuticals?
Motley Fool
0 shares
1 views
You might like
Related news coverage
The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time (MRNA)
Business Insider
· The biotech Moderna has skyrocketed to global prominence, leading the world's race for a coronavirus vaccine.
· The..
